Alzheimer’s disease 2020

Call for Papers

Alzheimer’s disease 2020 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Alzheimer’s disease and Dementia and share the cross-cultural experiences of various treatment procedures.

Alzheimer’s disease 2020 is an annual meeting of Neurologists as well as Neurology committees to discuss the future of the Alzheimer’s disease and Dementia in terms of collaboration, structures and organizational development and advances of Neurology.

Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 44 million people are living with dementia this number is expected to double by 2030 and more than triple by 2050 to 115 million. In 2011, an estimated 747,000 Canadians were living with Alzheimer’s or other alternative dementias by 2031, it is predictable that 1.4 million Canadians will have dementia. In Canada 72% of Alzheimer's sufferers are women and 62% of dementia cases are also women. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is predicted to double by 2030 and more than triple by 2050 to 115 million. No treatments available to slow or stop the brain damage caused by Alzheimer’s disease, several medications can temporarily help improve the symptoms of dementia for a few individuals. In two decades, it is predictable that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

Vascular dementia is widely considered the second most common cause of dementia after Alzheimer's disease, accounting for 10 percent of cases. Many specialists believe that vascular dementia remains underdiagnosed like Alzheimer's disease even though it's recognized as common.

Alzheimer’s disease 2020 provides more updates about Alzheimer’s and dementia care and research.